Related references
Note: Only part of the references are listed.Comprehensive Genetic Characterization of Human Thyroid Cancer Cell Lines: A Validated Panel for Preclinical Studies
Inigo Landa et al.
CLINICAL CANCER RESEARCH (2019)
Integrated Bioinformatics Analysis of Master Regulators in Anaplastic Thyroid Carcinoma
Zongfu Pan et al.
BIOMED RESEARCH INTERNATIONAL (2019)
Integrated Bioinformatics Analysis of Hub Genes and Pathways in Anaplastic Thyroid Carcinomas
Xueren Gao et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2019)
Quinone-Based Antitumor Agent Sepantronium Bromide (YM155) Causes Oxygen-Independent Redox-Activated Oxidative DNA Damage
Tasaduq H. Wani et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2018)
Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancers
Nikita Pozdeyev et al.
CLINICAL CANCER RESEARCH (2018)
Cytokeratin-8 in Anaplastic Thyroid Carcinoma: More Than a Simple Structural Cytoskeletal Protein
Dehuang Guo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600-Mutant Anaplastic Thyroid Cancer
Vivek Subbiah et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Real-World Experience with Targeted Therapy for the Treatment of Anaplastic Thyroid Carcinoma
Priyanka C. Iyer et al.
THYROID (2018)
YM155 sensitizes non-small cell lung cancer cells to EGFR-tyrosine kinase inhibitors through the mechanism of autophagy induction
Chun-Hua Dai et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)
NCCN Guidelines® Insights Thyroid Carcinoma, Version 2.2018 Featured Updates to the NCCN Guidelines
Robert I. Haddad et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2018)
Therapeutic advances in anaplastic thyroid cancer: a current perspective
Shikha Saini et al.
MOLECULAR CANCER (2018)
Differentiated and Anaplastic Thyroid Carcinoma: Major Changes in the American Joint Committee on Cancer Eighth Edition Cancer Staging Manual
Nancy D. Perrier et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Survivin Inhibitor YM155 Induces Mitochondrial Dysfunction, Autophagy, DNA Damage, and Apoptosis in Bcl-xL Silenced Glioma Cell Lines
Esther P. Jane et al.
MOLECULAR CARCINOGENESIS (2017)
R Loops and Links to Human Disease
Patricia Richard et al.
JOURNAL OF MOLECULAR BIOLOGY (2017)
YM155 induces apoptosis in p53-deficient T-acute lymphoblastic leukemia cells independent of survivin inhibition
Leilane Sales et al.
ANTI-CANCER DRUGS (2017)
Validation of JCountPro software for efficient assessment of ionizing radiation-induced foci in human lymphocytes
Lukas Jakl et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2016)
Increased global transcription activity as a mechanism of replication stress in cancer
Panagiotis Kotsantis et al.
NATURE COMMUNICATIONS (2016)
The Mechanism of Radiosensitization by YM155, a Novel Small Molecule Inhibitor of Survivin Expression, is Associated with DNA Damage Repair
Songliu Hu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
Antiproliferative, DNA intercalation and redox cycling activities of dioxonaphtho[2,3-d]imidazolium analogs of YM155: A structure-activity relationship study
Si-Han Sherman Ho et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
YM155 potently kills acute lymphoblastic leukemia cells through activation of the DNA damage pathway
Bill H. Chang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2015)
YM155 down-regulates survivin and XIAP, modulates autophagy and induces autophagy-dependent DNA damage in breast cancer cells
S. M. Cheng et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
YM155 sensitizes ovarian cancer cells to cisplatin inducing apoptosis and tumor regression
Roser Mir et al.
GYNECOLOGIC ONCOLOGY (2014)
Small-molecule survivin inhibitor YM155 enhances radiosensitization in esophageal squamous cell carcinoma by the abrogation of G2 checkpoint and suppression of homologous recombination repair
Qin Qin et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2014)
Arginine Methylation Facilitates the Recruitment of TOP3B to Chromatin to Prevent R Loop Accumulation
Yanzhong Yang et al.
MOLECULAR CELL (2014)
The solute carrier SLC35F2 enables YM155-mediated DNA damage toxicity
Georg E. Winter et al.
NATURE CHEMICAL BIOLOGY (2014)
Classification of follicular cell-derived thyroid cancer by global RNA profiling
Maria Rossing
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2013)
The survivin suppressants NSC 80467 and YM155 induce a DNA damage response
Trevor G. Glaros et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2012)
American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer
Robert C. Smallridge et al.
THYROID (2012)
γH2AX foci as a measure of DNA damage: A computational approach to automatic analysis
Alesia N. Ivashkevich et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2011)
Anaplastic Thyroid Carcinoma: Pathogenesis and Emerging Therapies
R. C. Smallridge et al.
CLINICAL ONCOLOGY (2010)
Detailed Molecular Fingerprinting of Four New Anaplastic Thyroid Carcinoma Cell Lines and Their Use for Verification of RhoB as a Molecular Therapeutic Target
Laura A. Marlow et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Topoisomerase I suppresses genomic instability by preventing interference between replication and transcription
Sandie Tuduri et al.
NATURE CELL BIOLOGY (2009)
Anaplastic thyroid cancer
Ryan L. Neff et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2008)
Mechanism of R-loop formation at immunoglobulin class switch sequences
Deepankar Roy et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
A cell proliferation and chromosomal instability signature in anaplastic thyroid carcinoma
Giuliana Salvatore et al.
CANCER RESEARCH (2007)
YM155, a novel small-molecule survivin suppressant, induces regression of established human hormone-refractory prostate tumor xenografts
Takahito Nakahara et al.
CANCER RESEARCH (2007)
Impairment of transcription elongation by R-loops in vitro
Cristina Tous et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Anaplastic thyroid carcinoma: Biology, pathogenesis, prognostic factors, and treatment approaches
C Are et al.
ANNALS OF SURGICAL ONCOLOGY (2006)
Peroxisome proliferator-activated receptor gamma activation induces cell cycle arrest via the p53-independent pathway in human anaplastic thyroid cancer cells
SH Chung et al.
JAPANESE JOURNAL OF CANCER RESEARCH (2002)
Anaplastic thyroid carcinoma: A 50-year experience at a single institution
B McIver et al.
SURGERY (2001)
Share Paper
